Trials / Completed
CompletedNCT01156012
Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 404 (actual)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and safety of T2345 versus active comparator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | T2345 | One drop of T2345 |
| DRUG | Prostaglandin | One drop |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-07-02
- Last updated
- 2015-01-22
- Results posted
- 2014-11-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01156012. Inclusion in this directory is not an endorsement.